Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Buse JB et al
, Swiss Pharmaceuticals BPC-157 60 Caps , ( )
The compound functions as a selective ghrelin receptor (GHS-R1a) agonist, demonstrating high binding affinity and activation specificity compared to other growth hormone releasing peptides
Clinical Benefits & Indications IGF-1 LR3 demonstrates therapeutic potential across multiple clinical domains, though current applications remain off-label and require careful patient selection and monitoring
It usually starts as a monoclonal disease and quickly progresses into a polyclonal disease
US$ 28.18
US$ 21.88
US$ 29.71
US$ 29.84
US$ 24.53
US$ 22.00
